Hemostemix (PreCerv Inc.) Retains Chris McNorgan PhD to License NCP-01 to Neural Electrode Brain Implant Company May 2, 2023 Read More »
Hemostemix’ Second Round Interviews with Executive Vice President Business Development Candidates April 3, 2023 Read More »
Hemostemix Engages Montreal’s RobboDesign to SEO its Website to Engage with 236 Million Peripheral Arterial Disease and Critical Limb Ischemia Patients Globally March 29, 2023 Read More »
Hemostemix’ “Your Fountain of Youth” Trademark Granted by Japan Patent Office January 26, 2023 Read More »
Hemostemix Hiring 4 New Biotechnologists in Montreal and Appling for Grants to Fund up to 75% of 5-Year Costs January 23, 2023 Read More »